ApprovalTrail

Medical device licence · 70976 · Class 2

HUMAN CD14 ANTIBODIES

Yes: licensed in Canada

Licence status Issued (active); first licensed March 27, 2006. It is in Health Canada’s list of active licences.
Licence number
70976
Licence holder
Life Technologies CorporationFrederick, MD, United States
Risk class
Class II (low to moderate risk)
Licence type
Device Family
First licensed
March 27, 2006
Devices covered
15

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • HUMAN CD14 ALEXA FLUOR 700 C CONJUGATE
  • HUMAN CD14 APC CONJUGATE
  • HUMAN CD14 APC- ALEXA FLUOR 750 CONJUGATE
  • HUMAN CD14 BIOTIN CONJUGATE
  • HUMAN CD14 FITC CONJUGATE
  • HUMAN CD14 FITC CONJUGATE
  • HUMAN CD14 PACIFIC BLUE CONJUGATE
  • HUMAN CD14 PACIFIC ORANGE CONJUGATE
  • HUMAN CD14 PE-CY 5.5 CONJUGATE
  • HUMAN CD14 PE-TEXAS RED CONJUGATE
  • HUMAN CD14 PERCP CONJUGATE
  • HUMAN CD14 PURIFIED ANTIBODY
  • HUMAN CD14 R-PE CONJUGATE
  • HUMAN CD14 R-PE CONJUGATE
  • HUMAN CD14 TRI-COLOR CONJUGATE

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.